InfuSystem Holdings (INFU) Share-based Compensation (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Share-based Compensation came in at $165000.0 in Q1 2026, down 85.11% YoY from $1.1 million in Q1 2025, and down 95.04% on a QoQ basis from $3.3 million in Q4 2025.
InfuSystem Holdings (INFU) Share-based Compensation (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 13 years of Share-based Compensation data on file, last reported at $165000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 85.11% year-over-year to $165000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 34.27% YoY) and the FY2025 annual result came in at $4.4 million, down 2.17% from the prior year.
- Share-based Compensation retreated to $165000.0 in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.3 million in Q4 2025 to a low of -$733000.0 in Q3 2025.
- A 5-year average of $993352.9 and a median of $661000.0 in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation surged 3757.63% — and 2025, when it slumped 127.64%.
- Tracing INFU's Share-based Compensation over 5 years: stood at $3.1 million in 2022, then sank by 59.23% to $1.3 million in 2023, then retreated by 7.14% to $1.2 million in 2024, then surged by 181.0% to $3.3 million in 2025, then plunged by 95.04% to $165000.0 in 2026.
- The last three Share-based Compensation figures came in at $165000.0 (Q1 2026), $3.3 million (Q4 2025), and -$733000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Mn |
| Jun 30, 2026 | 1.24 Mn |
| Mar 31, 2026 | 165,000.00 |
| Mar 31, 2026 | 165,000.00 |
| Dec 31, 2025 | 3.33 Mn |
| Dec 31, 2025 | 3.33 Mn |
| Sep 30, 2025 | -733,000.00 |
| Sep 30, 2025 | -733,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 259,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Mar 31, 2024 | 365,000.00 |